Xiaoling Wang

机构：Shanghai Jiao Tong University, Capital Medical University, Sichuan University, XinHua Hospital, Augusta University Health, Shandong Provincial Hospital, Beijing Children’s Hospital, Shandong First Medical University, East China Normal University · ORCID：0009-0004-8927-5381

发表论文 87 篇 · 总被引 1000 次 · h-index 19

代表论文

• Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy (2022 · Journal for ImmunoTherapy of Cancer · 被引 22)
• Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling (2022 · Stem Cell Research & Therapy · 被引 22)
• Cancer cell membrane-camouflaged pH-responsive nanoparticles for enhancing siRNA effect and synergistic anti-tumor therapy (2025 · Journal of Nanobiotechnology · 被引 15)
• Effects of resistance exercise in elderly cancer patients (2023 · African Health Sciences · 被引 13)
• Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFβ and Hedgehog signal pathway (2024 · Cellular Oncology · 被引 12)
• Low expression of PCK2 in breast tumors contributes to better prognosis by inducing senescence of cancer cells (2022 · IUBMB Life · 被引 10)